-

AHF Says US Taxpayers Co-own Moderna’s COVID-19 VAX Patent

AHF calls for full transparency; says Moderna and the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services (BARDA) should fully disclose total cost of the project and the amount and percentage share of costs provided by the U.S. government

BARDA reportedly provided $1.4 billion to the company to produce 100 million doses of the vaccine

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) called the recent announcement that Cambridge, Massachusetts-based biotechnology company Moderna has declared that it will not enforce its patent rights for its COVID-19 vaccine candidate during the pandemic if it gets approval from the U.S. Food and Drug Administration (FDA) a “positive development.” (read Moderna statement)

Moderna reportedly received over $1.4 billion from the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services (BARDA) to produce 100 million doses of its COVID-19 vaccine. “AHF agrees with many activists that as the ‘angel investor’ in the vaccine research, the U.S. taxpayer co-owns the patent,” said John Hassell, national director of advocacy for AHF. “In the spirit of full transparency, Moderna and BARDA should also fully disclose the total cost of the project to produce this vaccine for COVID-19 and the amount and percentage share of costs provided by the U.S. government.”

AHF also calls on Moderna and all other drug companies receiving taxpayer funds and taxpayer-funded research to make the COVID-19 vaccine available to the international community by withholding enforcement of their patents in order to make this lifesaving medicine available to rich and poor countries equally.

In a related action, the advocacy group Public Citizen said in a press statement that Moderna should “… dedicate its technology to the World Health Organization (WHO) so that the world can prepare to make vaccines for billions of people, rather than permit vaccine apartheid where only wealthy countries have vaccine access.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.4 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

MEDIA CONTACTS:
John Hassell, National Director of Advocacy, AHF
+1.202.774.4854 [cell] John.hassell@aidshealth.org

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell] +.323.308.1833 [work] gedk@aidshealth.org

AIDS Healthcare Foundation


Release Summary
AHF Says US Taxpayers Co-own Moderna’s COVID-19 VAX Patent
Release Versions

Contacts

MEDIA CONTACTS:
John Hassell, National Director of Advocacy, AHF
+1.202.774.4854 [cell] John.hassell@aidshealth.org

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell] +.323.308.1833 [work] gedk@aidshealth.org

More News From AIDS Healthcare Foundation

Club de Madrid and AHF Global Public Health Institute Co-Host High-Level Roundtable on Rebalancing Global Health

NEW YORK--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) Global Public Health Institute, Club de Madrid and partners will join the Governments of Spain and Zambia in co-hosting a high-level roundtable, “Rebalancing Global Health: Regional Platforms, Equity, and Fiscal Space for Public Health Security,” on Thursday, Sept. 24, 2026, from 8:30 to 10:30 a.m. at the University Club in New York City and online via Zoom. The event will occur on the margins of the 81st United Nations General Ass...

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

MEXICO CITY--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 countries across Latin America. The agreement represents a positive step toward expanding access in the region and a victory for civil society. AHF was among the first organizations to mobilize around concerns that the initial Gilead-...

AHF to Commemorate 40 Years of Global Impact During Annual World AIDS Day Concert Celebration

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/AIDS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. The event, which is free and open to the public, is scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California. RSVP to AHFWAD.org for tickets. Commemorated annually...
Back to Newsroom